Expression of activated signal transducer and activator Stat3 as a predictor of poor prognosis in cervical cancer

References

• Takemoto S, Ushijima K, Kawano K et al. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. Br. J. Cancer101(6), 967–972 (2009).
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin.55, 74–108 (2005).
   PubMed Web of Science ®Google Scholar
• Randall ME, Michael H, Long H 3rd, Tedjarati S. Uterine cervix. In: Principles and Practice of Gynecologic Oncology (5th Edition). Barakat RR, Markman M, Randall ME (Eds). Lippincott Williams & Wilkins, PA, USA, 623–682 (2009).
   Google Scholar
• Waggoner SE. Cervical cancer. Lancet361, 2217–2225 (2003).
   PubMed Web of Science ®Google Scholar
• Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol.23, 9408–9421 (2005).
   PubMed Web of Science ®Google Scholar
• Van Waes C. Nuclear factor-kB in development, prevention, and therapy of cancer. Clin. Cancer Res.13, 1076–1082 (2007).
   PubMed Web of Science ®Google Scholar
• Roberts PJ, Der CJ. Targeting the Raf–MEK–ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene26, 3291–3310 (2007).
   PubMed Web of Science ®Google Scholar
• Wegenka UM, Buschmann J, Lutticken C, Heinrich PC, Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell Biol.13, 2762–2788 (1993).
   Google Scholar
• Huang S. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin. Cancer Res.13, 1362–1366 (2007).
   PubMed Web of Science ®Google Scholar
• Shen Y, Schlessinger K, Zhu X et al. Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol. Cell Biol.24, 407–419 (2004).
   PubMed Web of Science ®Google Scholar
• Levy DC, Lee CK. What does Stat3 do? J. Clin. Invest.109, 1123–1148 (2002).
   Google Scholar
• Yu CL, Meyer DJ, Campbell GS et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science269, 81–83 (1995).
   PubMed Web of Science ®Google Scholar
• Ram PT, Horvath CM, Iyengar R. Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Galphao protein. Science287, 142–144 (2000).
   PubMed Web of Science ®Google Scholar
• Dechow TN, Pedranzini L, Leitch A et al. Requirement of matrixmetalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc. Natl Acad. Sci. USA101, 10602–10607 (2004).
   PubMed Web of Science ®Google Scholar
• Real P, Sierra A, De Juan A, Segovia J, Lopez-Vega J, Fernandez-Luna J. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene21, 7611–7618 (2002).
   PubMed Web of Science ®Google Scholar
• Wei L, Kuo M, Chen C et al. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene22, 1517–1527 (2003).
   PubMed Web of Science ®Google Scholar
• Wang T, Niu G, Kortylewski M et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med.10, 48–54 (2004).
   PubMed Web of Science ®Google Scholar
• Rosen DG, Mercado-Uribe I, Yang G et al. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer107, 2730–2740 (2006).
   PubMed Web of Science ®Google Scholar
• Chen CL, Hsieh FC, Lieblein JC et al. Stat3 activation in human endometrial and cervical cancers. Br. J. Cancer96, 591–599 (2007).
   PubMed Web of Science ®Google Scholar
• Xi S, Gooding WE, Grandis JR. In vivo antitumor efficacy of Stat3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene24, 970–979 (2005).
   PubMed Web of Science ®Google Scholar
• Turkson J, Zhang S, Mora LB, Burns A, Sebti S, Jove R. A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells. J. Biol. Chem.280, 32979–32988 (2005).
   PubMed Web of Science ®Google Scholar
• Duan Z, Bradner JE, Greenberg E et al. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation. Clin. Cancer Res.12, 6844–6852 (2006).
   PubMed Web of Science ®Google Scholar
• Hussain SF, Kong LY, Jordan J et al. A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res.67, 9630–9636 (2007).
   PubMed Web of Science ®Google Scholar
• Yu H, Jove R. The stats of cancer – new molecular targets come of age. Nat. Rev. Cancer4, 97–105 (2004).
   PubMed Web of Science ®Google Scholar